Form 4: Rocket Lab Executive Sells Shares for Tax, 10b5-1 Plan

Rocket Lab's SVP General Counsel & Secretary, Arjun Kampani, reported sales of common stock totaling 40,601 shares in September 2025.

Summary

• Arjun Kampani, SVP General Counsel & Secretary of Rocket Lab Corp (RKLB), reported multiple sales of common stock.
• A total of 40,601 shares were sold across two transaction dates: September 16, 2025, and September 17, 2025.
• On September 16, 2025, 31,185 shares were sold at weighted average prices ranging from $47.785 to $51.6341.
• These sales on September 16, 2025, were primarily 'sell-to-cover' transactions to satisfy tax withholding obligations related to the vesting and settlement of restricted stock units.
• On September 17, 2025, an additional 9,416 shares were sold at weighted average prices ranging from $47.1793 to $47.9506.
• The sales on September 17, 2025, occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kampani on December 12, 2024.
• Following these transactions, Mr. Kampani beneficially owns 489,629 shares of Rocket Lab common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The transactions are routine insider sales, primarily for tax obligations and a pre-scheduled 10b5-1 plan, which are not typically indicative of management's view on the company's future performance or significant operational changes.

Positives

• The sales were executed at relatively strong share prices, ranging from $47.1793 to $51.6341 per share.
• A significant portion of the sales were for tax withholding obligations, which is a routine and expected event for executives receiving equity compensation.
• Some sales were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a structured and pre-determined approach to stock liquidation rather than a reactive decision.

Negatives

• The transactions represent a reduction in direct beneficial ownership by a key executive, which can sometimes be perceived negatively by the market, even if for routine reasons.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• Sales on September 16, 2025, represent 'sell-to-cover' transactions to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units.
• Sales on September 17, 2025, occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.

Industry Context

This filing is a routine insider transaction report and does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The sale of shares by a key executive, even for routine reasons, may lead to minor market scrutiny, but the pre-planned nature and tax-related reasons mitigate significant negative impact.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

Rocket Lab, RKLB, Arjun Kampani, Insider Trading, Form 4, Stock Sale, Executive, 10b5-1 Plan, Restricted Stock Units, Tax Withholding